István Láng
National Institute of Oncology(HU)
Publications by Year
Research Areas
Breast Cancer Treatment Studies, Cancer Treatment and Pharmacology, HER2/EGFR in Cancer Research, Advanced Breast Cancer Therapies, Colorectal Cancer Treatments and Studies
Most-Cited Works
- → Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer(2005)5,074 cited
- → Cetuximab Plus Irinotecan, Fluorouracil, and Leucovorin As First-Line Treatment for Metastatic Colorectal Cancer: Updated Analysis of Overall Survival According to Tumor KRAS and BRAF Mutation Status(2011)1,880 cited
- → Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer(2017)1,370 cited
- → Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial(2015)1,174 cited
- → Five Years of Letrozole Compared With Tamoxifen As Initial Adjuvant Therapy for Postmenopausal Women With Endocrine-Responsive Early Breast Cancer: Update of Study BIG 1-98(2007)901 cited
- → Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast Cancer(2014)740 cited
- → Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer(2018)651 cited
- → Bevacizumab plus capecitabine versus capecitabine alone in elderly patients with previously untreated metastatic colorectal cancer (AVEX): an open-label, randomised phase 3 trial(2013)646 cited
- → Multicenter Phase III Comparison of Cisplatin/S-1 With Cisplatin/Infusional Fluorouracil in Advanced Gastric or Gastroesophageal Adenocarcinoma Study: The FLAGS Trial(2010)565 cited
- → Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): survival outcomes of a randomised, open-label, multicentre, phase 3 trial and their association with pathological complete response(2014)454 cited